119th Congress · HOUSE BILLBILL

H.R. 10857 — To amend the Federal Food, Drug, and Cosmetic Act and Public Health Service Act to advance the next-generation of clinical development of novel treatments and cures, and for other purposes.

“To amend the Federal Food, Drug, and Cosmetic Act and Public Health Service Act to advance the next-generation of clinical development of novel treatments and cures, and for other purposes.”

Introduced Oct 22, 2026

Last action Oct 22, 2026

Pipeline · Bill → Law

Step 1

Introduced

Oct 22, 2026

Step 2

Referred

Oct 22, 2026

E&C · Ways & Means

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 0 sections

No provisions parsed for this bill.

Timeline · 2 actions

Oct 22, 2026

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Oct 22, 2026

Introduced in House